Fremanezumab

FDA Drug Profile

Drug Details

Generic Name
Fremanezumab
Brand Names
N/A
Application Number
Sponsor
Lonza Biologics, Inc.
NDC Codes
1
Dosage Forms
LIQUID
Routes
N/A
Active Ingredients
FREMANEZUMAB

Indications and Usage

1 INDICATIONS AND USAGE AJOVY is indicated for: the preventive treatment of migraine in adults, and the preventive treatment of episodic migraine in pediatric patients who are 6 to 17 years of age and who weigh 45 kg or more. AJOVY is a calcitonin gene-related peptide antagonist indicated for: the preventive treatment of migraine in adults, and the preventive treatment of episodic migraine in pediatric patients who are 6 to 17 years of age and who weigh 45 kg or more. ( 1 )